Routine hepatitis B immunisation in India: cost-effectiveness assessment.
Indian J Pediatr
; 2000 Apr; 67(4): 299-300
Article
in En
| IMSEAR
| ID: sea-81723
Based on World Bank guidelines, hepatitis B immunization would be an excellent public health investment, saving each life year for well below the per-capita gross domestic product. This would be one of the most cost-effective investments India could make in the field of health.
Full text:
1
Index:
IMSEAR
Main subject:
Humans
/
Child
/
Cost-Benefit Analysis
/
Hepatitis B Vaccines
/
Immunization Programs
/
India
Type of study:
Health_economic_evaluation
Country/Region as subject:
Asia
Language:
En
Journal:
Indian J Pediatr
Year:
2000
Type:
Article